MNTK leads EPS-revision gainers +26.7%; HOOD surges 18%
EPS revision screeners flagged MNTK, FTH, HOOD, GOTU, and GEMI after analysts raised forward earnings estimates. MNTK gained 26.7% (from $1.76 to $2.23) on a 35.3% EPS growth estimate, while HOOD jumped 18.0% (to $122.11) amid bullish analyst upgrades and rising bitcoin. FTH (+18.4%), GOTU (+17.0%), and GEMI (+12.5%) followed, driven by sector momentum and sharp estimate revisions.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| MNTK | Basic Materials | 2026-09-01 | N/A | +26.7% |
| FTH | Healthcare | 2026-08-30 | +1.2pp | +18.4% |
| HOOD | Financial | 2026-09-01 | N/A | +18.0% |
| GOTU | Consumer Defensive | 2026-08-30 | +187.3pp | +17.0% |
| GEMI | Financial | 2026-09-01 | N/A | +12.5% |
Why did MNTK stock jump in September 2026?
MNTK jumped 26.7% (from $1.76 to $2.23) after the screener detected a revised EPS growth estimate of 35.3% for next year on September 1.
The move came without any earnings-related news in the window, suggesting the rally was driven purely by the improved earnings outlook. As a renewable fuels producer in the Basic Materials sector, MNTK likely benefited from sector tailwinds in clean energy and regulatory support, though no specific catalyst was reported. The price action confirms the market is rewarding the upward revision.
MNTK EPS revision history → · Screener snapshot from 2026-09-01 →
FAQ: MNTK
Why did MNTK stock jump?
MNTK rose 26.7% from $1.76 to $2.23 after analysts raised its next-year EPS growth estimate to 35.3% on September 1, signaling stronger expected profitability.
Is MNTK a buy after the rally?
The rally reflects a higher earnings estimate, but without news catalysts, investors should weigh the sustainability of the 35.3% EPS growth projection. Current price is $2.23, up from $1.76.
What caused MNTK's surge?
The surge was driven by an upward EPS revision detected by our screener, which raised next-year growth to 35.3%. No earnings-related news was found in the window, so the move appears estimate-driven.
Why did FTH stock jump in September 2026?
FTH jumped 18.4% (from $33.84 to $40.05) after analysts raised its forward EPS growth estimate from 77.6% to 78.7% on August 30.
No earnings-related news surfaced in the window, but the revision signal was strong enough to attract buying interest. As a healthcare company, FTH may have benefited from positive sector momentum, though the specific price driver appears tied to the growth estimate upgrade. The stock's gain since detection aligns with the improved earnings outlook.
FTH EPS revision history → · Screener snapshot from 2026-08-30 →
FAQ: FTH
Why did FTH stock jump?
FTH advanced 18.4% from $33.84 to $40.05 after analysts raised its EPS growth estimate from 77.6% to 78.7% on August 30.
What is FTH's EPS growth estimate?
FTH's next-year EPS growth estimate stands at 78.7%, up from 77.6% after the revision.
What caused FTH's surge?
The surge was driven by an upward EPS revision, with growth estimate rising 1.2 percentage points to 78.7%. No earnings-related news was reported in the window.
Why did HOOD stock jump in September 2026?
HOOD jumped 18.0% (from $103.51 to $122.11) after analysts revised its forward EPS growth to 34.2% on September 1, and Wall Street upgrades reinforced the move.
Morgan Stanley raised its rating to Overweight with a $150 target (from $124), citing asset growth and wallet share gains, while Scotiabank launched coverage bullish. The surge was amplified by bitcoin's climb to ~$81,500, as crypto-related stocks rallied. Investopedia reported HOOD led the S&P 500, jumping nearly 17% in a single session.
HOOD EPS revision history → · Screener snapshot from 2026-09-01 →
FAQ: HOOD
Why did HOOD stock jump?
HOOD rose 18.0% from $103.51 to $122.11 after EPS growth estimates were revised to 34.2% and analysts upgraded ratings, with bitcoin strength boosting crypto-related sentiment.
Is HOOD a buy after the rally?
Analysts are bullish: Morgan Stanley upgraded to Overweight with a $150 target, and Scotiabank launched with positive coverage, citing platform expansion and asset growth.
What caused HOOD's surge?
The surge was driven by an EPS revision, analyst upgrades (Morgan Stanley, Scotiabank, Piper Sandler), and a bitcoin rally near $81,500, lifting crypto-linked stocks.
Why did GOTU stock jump in September 2026?
GOTU jumped 17.0% (from $1.88 to $2.20) after analysts raised its next-year EPS growth estimate from 2722.7% to 2910.0% on August 30 — a massive +187.3 percentage-point revision.
No earnings-related news appeared in the window, but the dramatic estimate increase likely signaled a strong earnings turnaround story. As an ADR in the Consumer Defensive sector (education), the stock may have drawn interest from value and growth investors betting on recovery. The price gain since detection mirrors the scale of the revision.
GOTU EPS revision history → · Screener snapshot from 2026-08-30 →
FAQ: GOTU
Why did GOTU stock jump?
GOTU jumped 17.0% from $1.88 to $2.20 after analysts revised its next-year EPS growth estimate up to 2910.0%, a +187.3pp increase.
What is GOTU's EPS growth estimate?
GOTU's next-year EPS growth estimate is 2910.0%, up from 2722.7% following the revision.
What caused GOTU's surge?
The surge was driven solely by the upward EPS revision; no earnings-related news was reported in the window. The monster estimate jump likely attracted growth-oriented buyers.
Why did GEMI stock jump in September 2026?
GEMI jumped 12.5% (from $4.16 to $4.68) after analysts set a forward EPS growth estimate of 25.9% on September 1.
No earnings-related news surfaced, but the financial sector's momentum seems to have supported the move. The stock's gain since detection suggests investors are rewarding the improved profitability outlook. Without company-specific catalysts, the rise reflects confidence in the revised earnings trajectory.
GEMI EPS revision history → · Screener snapshot from 2026-09-01 →
FAQ: GEMI
Why did GEMI stock jump?
GEMI gained 12.5% from $4.16 to $4.68 after analysts revised its next-year EPS growth estimate to 25.9% on September 1.
Is GEMI a buy after the rally?
The upward EPS revision to 25.9% growth signals improved earnings expectations, but no news catalysts were found, so investors should monitor the company's execution.
What caused GEMI's surge?
The surge was driven by the positive EPS revision detected by our screener; no earnings-related news was reported in the window.
Today's top EPS-revision gainers highlight that upward earnings estimate revisions, even in the absence of news, can trigger significant price appreciation. Sector dynamics (crypto-linked, healthcare, renewable) and large estimate changes amplify the effect, reinforcing the value of systematic revision screening.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →